Sep 15, 2022 / 03:00PM GMT
John Bedford - Danaher Corporation - VP of IR
Good morning, everybody. I guess good afternoon. We just turned to 12:00 here. So thank you all for coming here. We got a full crowd here. I'm sure we have a full crowd on the webcast here. It's been 3 years since we've been in person. So we're really excited here to welcome you all to Cytiva and learn a little bit more about the our bioprocessing business, and Rainer will be up here to make some opening remarks shortly as well. Before we get started, I have to read. Today's presentation may include forward-looking statements, and actual results may differ materially from these statements. Please refer to the slide show and in our website for more information here.
With that, again, have a really great day here for you. We're going to start, Rainer is going to come up and make some opening remarks, certainly commenting a little bit on the news from last night. We'll then go to Biotechnology Group here where Emmanuel Ligner and team will really give you a little bit more look under the hood of the great businesses that we have here with Pall and Cytiva,
Danaher Corp Bioprocessing Analyst & Investor Day Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers